ClinicalTrials.Veeva

Menu

Study in Patients With Solid Tumor Regarding Access to Dermo-cosmetics and Aesthetic Solutions (DERMOCOS)

I

Institut de cancérologie Strasbourg Europe

Status

Enrolling

Conditions

Neoplasms

Treatments

Other: Questionnaires

Study type

Observational

Funder types

Other

Identifiers

NCT05907551
2023-001
2023-A00546-39 (Other Identifier)

Details and patient eligibility

About

Cancer treatments can trigger cutaneous side-effects, as well as nail and hair toxicities. When related to drug treatment, this iatrogeny depends on the type of drug, its dosage and individual susceptibility. Although these dermatological adverse events are rarely serious, they can significantly alter patients' quality of life, and may even necessitate the introduction of curative treatment.

The impact of these side effects can be mitigated by the use of dermo-cosmetic products and aesthetic solutions. However, most of this supportive care is not reimbursed by the health insurance system, representing a source of inequalities in access to healthcare for cancer patients.

Full description

This study aims at establishing, in a cohort of patients with solid tumors, the state of their knowledges, given information and their financial capacities regarding access to dermo-cosmetics and aesthetic solutions, that are used in the attenuation of cancer treatments' side-effects.

Enrollment

210 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age > 18 years
  • Patients with solid tumors (eligible localization include: digestive system, Head and Neck, Breast, Brain, Lung Tumors, Urological and Gynecologic cancers)
  • Patients able to read and understand French
  • Patients that has expressed their consent and with signed consent form

Exclusion criteria

  • Minor or patients placed under guardianship or supervision
  • Patients unable to read French
  • Patients placed under judicial protection

Trial design

210 participants in 7 patient groups

Patients with Digestive System Cancer
Treatment:
Other: Questionnaires
Patients with Head and Neck Cancer
Treatment:
Other: Questionnaires
Patients with Breast Cancer
Treatment:
Other: Questionnaires
Patients with Nervous System Tumors
Treatment:
Other: Questionnaires
Patients with Urological Cancer
Treatment:
Other: Questionnaires
Patients with Lung Cancer
Treatment:
Other: Questionnaires
Patients with Gynecologic Cancer
Treatment:
Other: Questionnaires

Trial contacts and locations

1

Loading...

Central trial contact

Claire VIT; Manon VOEGELIN

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems